Skip to main content

Table 1 Clinical characteristics (pre-LT)

From: Safety evaluation of curative gastrectomy for gastric cancer patients who underwent liver transplantation: a comparative study with conventional gastrectomy for gastric cancer patients

Variable

Curative gastrectomy after LT (n = 32)

Age at LT

64.06 ± 8.67

Gender (M:F)

28:4

Pretransplant diagnosis

 HBV LC

23 (71.88)

 HCV LC

2 (6.25)

 Alcoholic LC

7 (21.88)

 Other

1 (3.13)

 Concurrent HCC

14 (43.75)

 Child Pugh score

10.94 ± 2.20

 MELD score

21.90 ± 8.73

Type of LT

 DDLT

4 (12.50)

 LDLT (Rt graft)

19 (59.38)

 LDLT (Lt graft)

4 (12.50)

 LDLT (Dual donor)

5 (15.63)

Biliary anastomosis

 Duct to duct

22 (68.75)

 Hepaticojejunostomy

10 (31.25)

  1. Values are expressed as the mean ± SD or number (%)
  2. LT liver transplant, HBV hepatitis B virus, HCV hepatitis C virus, LC liver cirrhosis, HCC hepatocellular carcinoma, MELD model for endstage liver disease, DDLT deceased donor liver transplant, LDLT living donor liver transplant, SD standard deviation